Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-08-18 | 2025-08-18 |
| Drug Identification Number | 02241807 | 02241807 |
| Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
| Common or Proper name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | VANCOMYCIN | VANCOMYCIN |
| Strength(s) | 10G | 10G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 g | 10 g |
| ATC code | J01XA | J01XA |
| ATC description | OTHER ANTIBACTERIALS | OTHER ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2025-08-18 | 2025-08-18 |
| Estimated end date | 2025-09-19 | 2025-09-19 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Due to a delay in the release, we will be encountering a supply interruption on our Vancomycin Hydrochloride for Injection, USP 10 g Vial, effective August 18, 2025, until September 19, 2025. | Due to a delay in the release, we will be encountering a supply interruption on our Vancomycin Hydrochloride for Injection, USP 10 g Vial, effective August 18, 2025, until September 19, 2025. |
| Health Canada comments |